MARC details
000 -LEADER |
fixed length control field |
03084cam a22005054a 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
CUTN |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20190829153639.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
030730s2004 njua b 001 0 eng |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
1588290832 (alk. paper) |
041 ## - LANGUAGE CODE |
Language |
English |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
060 #0 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
W1 |
Item number |
ME9616JM v.93 2003 |
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
QZ 170 |
Item number |
A629 2003 |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.718 |
Edition number |
22 |
Item number |
MOU |
100 ## - MAIN ENTRY--PERSONAL NAME |
Personal name |
Mousa, Shaker A. |
245 00 - TITLE STATEMENT |
Title |
Anticoagulants, antiplatelets, and thrombolytics / |
Statement of responsibility, etc |
edited by Shaker A. Mousa. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
Totowa, N.J. : |
Name of publisher, distributor, etc |
Humana Press, |
Date of publication, distribution, etc |
c2004. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
x, 307 p. : |
Other physical details |
ill. ; |
Dimensions |
24 cm. |
440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE |
Title |
Methods in molecular medicine ; |
Volume number/sequential designation |
93 |
505 ## - FORMATTED CONTENTS NOTE |
Title |
Highlights of latest advances in antithrombotics <br/> |
-- |
Antiplatelet, anticoagulant, and thrombolytic drug interactions <br/> |
-- |
Evaluation of platelet antagonists in in vitro flow models of thrombosis |
-- |
Heparin and low molecular weight heparin in thrombosis, cancer, and inflammatory diseases <br/> |
-- |
Are low molecular weight heparins the same? |
-- |
Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia <br/> |
-- |
Laboratory methods for heparin-induced thrombocytopenia<br/> |
-- |
Factor Xa inhibitors |
-- |
Tissue factor/VIIa in thrombosis and cancer |
-- |
Tissue factor pathway inhibitor in thrombosis and beyond |
-- |
Cell adhesion molecules: potential therapeutic and diagnostic implications<br/> |
-- |
Development and applications of animal models of thrombosis |
-- |
A survey of venous thrombosis models |
-- |
Arixtra (fondaparinux sodium) |
-- |
Oral thrombin inhibitor ximelagatran |
-- |
Pharmacogenomics and coagulation disorders |
-- |
Guidelines for diagnosis and treatment of deep venous thrombosis and pulmonary embolism |
520 ## - SUMMARY, ETC. |
Summary, etc |
<br/>"During the past decade, remarkable progress has been made in the development of new drugs to treat thrombotic and cardiovascular diseases, the number one cause of mortality worldwide. In Anticoagulants, Antiplatelets, and Thrombolytics, leading experts with established records of discovery and invention highlight the latest developments in antithrombotics and provide experimental methods for the discovery of new Read more... |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Anticoagulants (Medicine) |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Blood platelets. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Thrombolytic therapy. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Fibrinolytic agents. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Anticoagulants |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Thrombolytic Therapy |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Fibrinolytic Agents |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Heparin |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Platelet Aggregation Inhibitors |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Thrombocytopenia |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Mousa, Shaker A. |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Dewey Decimal Classification |
Koha item type |
General Books |
856 41 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="http://www.loc.gov/catdir/toc/ecip047/2003017231.html">http://www.loc.gov/catdir/toc/ecip047/2003017231.html</a> |
856 42 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="http://www.loc.gov/catdir/enhancements/fy0826/2003017231-d.html">http://www.loc.gov/catdir/enhancements/fy0826/2003017231-d.html</a> |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references and index. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
General subdivision |
therapeutic use. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
General subdivision |
methods. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
General subdivision |
therapeutic use. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
General subdivision |
therapeutic use. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
General subdivision |
therapeutic use. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
General subdivision |
drug therapy. |
856 41 - ELECTRONIC LOCATION AND ACCESS |
Materials specified |
Table of contents |
856 42 - ELECTRONIC LOCATION AND ACCESS |
Materials specified |
Publisher description |
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
a |
7 |
b |
cbc |
c |
orignew |
d |
1 |
e |
ecip |
f |
20 |
g |
y-gencatlg |